MAIT cells promote cancer progression and regulatory T cell accumulation in bladder tumor microenvironment
Journal for ImmunoTherapy of Cancer · 2025-09 · 13 (9) · e012496
DOI: 10.1136/jitc-2025-012496 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal for ImmunoTherapy of Cancer, online erschienen am 15.09.2025. Verfasst von Inbar A Habaz und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, Western University, London, Ontario, Canada. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Tumor Microenvironment, Mucosal-Associated Invariant T Cells, T-Lymphocytes, Regulatory. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Natural Sciences and Engineering Research Council of Canada, Government of Ontario, Canadian Institutes of Health Research.
Abstract (Originalsprache)
Background
Mucosa-associated invariant T (MAIT) cells represent a unique population of innate-like T lymphocytes capable of detecting non-peptide antigens in the context of monomorphic antigen-presenting molecules. Due to their abundance in barrier tissues, reactivity to local inflammatory cues, and cytotoxic and regulatory functions, MAIT cells are poised to shape the dynamics of various tumor microenvironments. Growing evidence suggests that MAIT cells can exert protumor and/or antitumor effects in cancers arising from or metastasizing to mucosal tissues. However, MAIT cell roles in bladder cancer (BCa) remains unclear.
Methods
To begin to identify MAIT cells in BCa, we stained bladder tumor biopsies for T cell receptor (TCR) Vα7.2 + cells. We then refined a human MAIT cell signature, which enabled us to interrogate a bulk RNA sequencing dataset and conduct correlation analyses linking intratumoral MAIT cell abundance and mortality from BCa. To extend our work to an in vivo setting, we employed a clinically relevant mouse model in which Mr1 +/+ B6-MAIT CAST (MAIT-sufficient) and Mr1 −/− B6-MAIT CAST (MAIT-deficient) mice were exposed to N-butyl-N-(4-hydroxybutyl)nitrosamine, a chemical carcinogen associated with tobacco smoke. In additional experiments, MAIT cells were functionally removed through acetyl-6-formylpterin (Ac-6-FP) administration. Effector and regulatory cell types were phenotyped by flow cytometry, and BCa tumor burden and progression were assessed by MRI and/or H&E and Ki67 staining.
Results
TCR Vα7.2 + cells were readily detectable in several BCa biopsies, and our bioinformatic analyses correlated heavier MAIT cell presence in BCa tumors with poorer overall survival. Similarly, we found higher tumor burdens in Mr1 +/+ B6-MAIT CAST mice than in Mr1 −/− or Ac-6-FP-treated animals. Bladder MAIT cells from tumor-bearing mice exhibited phenotypic MAIT17 bias based on transcription factors they harbored along with increased interleukin-17A and tumor necrosis factor-α production capacities upon stimulation. Finally, FoxP3 + regulatory T (T reg ) cell frequencies were elevated in Mr1 +/+ mouse bladder tumors, likely contributing to an immunosuppressive tumor microenvironment, a finding that could be recapitulated in our transcriptomic studies on human BCa.
Conclusions
MAIT cells are abundant in BCa tumor microenvironments where they potentiate T reg cell accumulation and play protumor roles.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Microbiology and Immunology, Western University, London, Ontario, Canada.
- Division of Thoracic Tumor Multimodality Treatment, Cancer Center, West China Hospital, Chengdu, Sichuan, China.
- Imaging Laboratories, Robarts Research Institute, Western University, London, Ontario, Canada.
- Department of Urology, West China Hospital, Chengdu, Sichuan, China.
- Charles River Laboratories, Laval, Quebec, Canada.
- Division of Urology, Department of Surgery, Western University, London, Ontario, Canada.
Förderung
- Natural Sciences and Engineering Research Council of Canada
- Government of Ontario
- Canadian Institutes of Health Research
- Cancer Research Society
Zitieren
APA
Habaz, I. A., Ou, X., Wang, N. I., Schincaglia, A., Shydlouskaya, V., Mahendran, A., Martinez-Santiesteban, F. M., Doolabi, D., Bao, Y., Movasseghi, A. R., Haruna, J., Power, N. E., Scholl, T. J., Huynh, M. J., Sener, A., & Haeryfar, S. M. M. (2025). MAIT cells promote cancer progression and regulatory T cell accumulation in bladder tumor microenvironment. Journal for ImmunoTherapy of Cancer, 13(9), e012496. https://doi.org/10.1136/jitc-2025-012496
Vancouver
Habaz IA, Ou X, Wang NI, Schincaglia A, Shydlouskaya V, Mahendran A, et al. MAIT cells promote cancer progression and regulatory T cell accumulation in bladder tumor microenvironment. Journal for ImmunoTherapy of Cancer. 2025;13(9):e012496. doi:10.1136/jitc-2025-012496
BibTeX
@article{Habaz2025,
author = {Habaz, Inbar A and Ou, Xuejin and Wang, Nicole I and Schincaglia, Angela and Shydlouskaya, Valeryia and Mahendran, Agetha and Martinez-Santiesteban, Francisco M and Doolabi, Dylan and Bao, Yige and Movasseghi, Ahmad R and Haruna, Julius and Power, Nicholas E and Scholl, Timothy J and Huynh, Melissa J and Sener, Alp and Haeryfar, S M Mansour},
title = {MAIT cells promote cancer progression and regulatory T cell accumulation in bladder tumor microenvironment},
journal = {Journal for ImmunoTherapy of Cancer},
year = {2025},
volume = {13},
number = {9},
pages = {e012496},
doi = {10.1136/jitc-2025-012496}
}
EUVIMED